More macrolides.
- 14 September 1991
- Vol. 303 (6803) , 594-595
- https://doi.org/10.1136/bmj.303.6803.594
Abstract
No abstract availableThis publication has 19 references indexed in Scilit:
- Mycoplasma pneumoniaeThe Lancet, 1991
- Comparative study of clarithromycin and roxithromycin in the treatment of community-acquired pneumoniaJournal of Antimicrobial Chemotherapy, 1991
- Chemotherapy for infections caused by Haemophilus influenzae: current problems and future prospectsJournal of Antimicrobial Chemotherapy, 1991
- Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humansAntimicrobial Agents and Chemotherapy, 1990
- Azithromyrin (CP-62,993) in acute exacerbations of chronic bronchitis: an open clinical, microbiological and pharmacokinetic studyJournal of Antimicrobial Chemotherapy, 1989
- Comparative in vitro activities of new 14-, 15-, and 16-membered macrolidesAntimicrobial Agents and Chemotherapy, 1988
- Bioassay for A-56268 (TE-031) and identification of its major metabolite, 14-hydroxy-6-O-methyl erythromycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- A NewChlamydia psittaciStrain, TWAR, Isolated in Acute Respiratory Tract InfectionsNew England Journal of Medicine, 1986
- Antibacterial activity of roxithromycin: A laboratory evaluation.The Journal of Antibiotics, 1986
- Erythromycin: A Microbial and Clinical Perspective After 30 Years of Clinical Use (Second of Two Parts)Mayo Clinic Proceedings, 1985